Vollins James 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Vollins James
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-01-31+8,303→ 24,579 total - Exercise/Conversion
Common Stock
2022-01-31+3,834→ 28,413 total - Exercise/Conversion
Restricted Stock Units
2022-01-29−8,303→ 8,303 totalExercise: $0.00Exp: 2023-01-29→ Common Stock (8,303 underlying) - Award
Restricted Stock Units
2022-01-27+50,546→ 50,546 totalExercise: $0.00Exp: 2025-01-27→ Common Stock (50,546 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-31−3,834→ 0 totalExercise: $0.00Exp: 2022-01-31→ Common Stock (3,834 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-27−16,276→ 32,552 totalExercise: $0.00Exp: 2024-01-27→ Common Stock (16,276 underlying) - Award
Stock Options (right to buy)
2022-01-27+282,055→ 282,055 totalExercise: $3.66Exp: 2032-01-26→ Common Stock (282,055 underlying) - Exercise/Conversion
Common Stock
2022-01-27+16,276→ 16,276 total
Footnotes (7)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
- [F2]The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F3]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F4]Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
- [F5]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 27, 2021, under the Plan. The remaining RSUs vest in equal portions on: (i) January 27, 2023; and (ii) January 27, 2024.
- [F6]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 29, 2020, under the Issuer's 2019 Plan. The remaining RSUs vest on January 29, 2023.
- [F7]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 31, 2019, under the Issuer's 2011 Equity Incentive Plan, as amended.